ask="N/A"
ask_size="N/A"
average_daily_volume="53036"
bid="1.50"
bid_size="2000"
book_value="0.81"
change="-0.08"
change_from_200_day_moving_average="0.04"
change_from_50_day_moving_average="0.17"
change_from_52_week_high="-1.89"
change_From_52_week_low="0.57"
change_in_percent="-4.28%"
close="1.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.85"
high_52_weeks="3.68"
last_trade_date="2/10/2017"
last_trade_price="1.79"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.79"
low_52_weeks="1.22"
market_capitalization="19.67M"
moving_average_200_day="1.75"
moving_average_50_day="1.62"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.83"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.58%"
percent_change_from_50_day_moving_average="+10.39%"
percent_change_from_52_week_high="-51.36%"
percent_change_from_52_week_low="+46.72%"
previous_close="1.87"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.31"
price_per_sales="5.41"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.08"
stock_exchange="NCM"
symbol="CBLI"
volume="9505"
weeks_range_52="1.22 - 3.68"
